Susan Horwitz

Title: Susan Horwitz: Innovator in Antineoplastic Research

Introduction

Susan Horwitz is a prominent inventor based in Larchmont, NY (US). She has made significant contributions to the field of medical research, particularly in the development of innovative treatments for neoplasia. With a total of 3 patents, her work has had a profound impact on cancer therapy.

Latest Patents

Among her latest patents is the "Human βV-tubulin antibody and methods of use." This patent provides antibodies to human βV-tubulin, fragments thereof, and compositions comprising such. It also outlines diagnostic, prognostic, and identification methods employing these antibodies or fragments. Another notable patent is the "Method for treating neoplasia using combination chemotherapy." This invention describes a synergistic combination of known antineoplastic agents that offers greater efficacy than the single agents alone. The method involves administering an effective amount of paclitaxel in combination with discodermolide to achieve a synergistic antineoplastic effect.

Career Highlights

Susan has worked with esteemed institutions such as the Albert Einstein College of Medicine and the Wisconsin Alumni Research Foundation. Her research has been pivotal in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Some of her notable coworkers include Hayley Maria McDaid and Yihong Wang. Their collaborative efforts have contributed to the success of her research initiatives.

Conclusion

Susan Horwitz stands out as an influential inventor in the realm of cancer research, with her innovative patents paving the way for new treatment options. Her dedication to advancing medical science continues to inspire future generations of researchers.